The influence of HIV on CD127 expression and its potential implications for IL-7 therapy.

Interleukin-7 (IL-7) is critical for early T-cell development and plays an important role in T-cell homeostasis, differentiation and function. Signalling via the IL-7 receptor is dependent on the expression of its components, IL-7Rα (CD127) and IL-2Rγ (CD132) and is mediated in part by alterations in CD127 expression levels in different cell subsets. Naïve and memory T-cells express high levels of CD127, while effector cells are CD127(lo) and retention of the receptor is thought to influence the development of memory cells. Reduced expression of CD127 has been associated with markers of disease severity in HIV infection and other chronic viral infections as well as in various cancers. In HIV infection, decreased CD127 expression on T-cells is correlated with reduced CD4(+) T-cell counts, increased viral replication and immune activation. The loss of IL-7 activity, due to decreased CD127 expression, may contribute to the observed loss of CD8(+) cytotoxic T lymphocyte (CTL) activity in HIV infection. The downregulation of CD127 expression in HIV infection may be due to host (e.g. IL-7, IL-4, immune activation) and/or viral (e.g. HIV-tat) factors and mechanisms of receptor regulation may differ by cell type. In addition, the expression of a soluble form of CD127 (sCD127) has been shown to be increased in HIV infection. This protein may affect IL-7 activity in vivo and therefore may have implications for IL-7-based therapies which are currently being tested in clinical trials. Understanding how CD127 is regulated during HIV infection will provide insight for the development of novel therapeutics to improve immune function and anti-viral T-cell activity.

[1]  K. Fowke,et al.  Loss of CD127 expression links immune activation and CD4(+) T cell loss in HIV infection. , 2008, Trends in microbiology.

[2]  R. DePinho,et al.  IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology , 2011, Cell.

[3]  D. Fearon,et al.  Pathways of memory CD8+ T‐cell development , 2009, European journal of immunology.

[4]  A. d’Arminio Monforte,et al.  Pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients , 2010, AIDS.

[5]  S. Ziegler,et al.  Cloning of the human and murine interleukin-7 receptors: Demonstration of a soluble form and homology to a new receptor superfamily , 1990, Cell.

[6]  A. Singer,et al.  Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. , 2004, Immunity.

[7]  I. Kang,et al.  Down-regulation of IL-7Ralpha expression in human T cells via DNA methylation. , 2007, Journal of immunology.

[8]  Ashok Kumar,et al.  Inverse association of repressor growth factor independent-1 with CD8 T cell interleukin (IL)-7 receptor α expression and limited signal transducers and activators of transcription signaling in response to IL-7 among γ-chain cytokines in HIV patients , 2009, AIDS.

[9]  O. Lambotte,et al.  Regulatory Dysfunction of the Interleukin-7 Receptor in CD4 and CD8 Lymphocytes From HIV-Infected Patients-Effects of Antiretroviral Therapy , 2006, Journal of acquired immune deficiency syndromes.

[10]  S. Nishikawa,et al.  Expression and function of the interleukin 7 receptor in murine lymphocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C. Tremblay,et al.  Persistent human immunodeficiency virus‐1 antigenaemia affects the expression of interleukin‐7Rα on central and effector memory CD4+ and CD8+ T cell subsets , 2008, Clinical and experimental immunology.

[12]  C. Rouzioux,et al.  Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. , 2009, The Journal of clinical investigation.

[13]  I. Kang,et al.  Altered IL-7Ralpha expression with aging and the potential implications of IL-7 therapy on CD8+ T-cell immune responses. , 2006, Blood.

[14]  J. Corbeil,et al.  Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2. , 2003, The Journal of infectious diseases.

[15]  P. Sellier,et al.  Interleukin-2 therapy in patients with HIV infection. , 2010, The New England journal of medicine.

[16]  N. Taylor,et al.  IL-7Rα Gene Expression Is Inversely Correlated with Cell Cycle Progression in IL-7-Stimulated T Lymphocytes1 , 2006, The Journal of Immunology.

[17]  E. Bosmans,et al.  Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection. , 1998, Immunology letters.

[18]  S. Levine,et al.  Mechanisms of Soluble Cytokine Receptor Generation , 2004, The Journal of Immunology.

[19]  B. Masquelier,et al.  Virological characterization of an infection with a dual-tropic, multidrug-resistant HIV-1 and further evolution on antiretroviral therapy , 2007, AIDS.

[20]  J. Angel,et al.  Interleukin‐7 enhances memory CD8+ T‐cell recall responses in health but its activity is impaired in human immunodeficiency virus infection , 2010, Immunology.

[21]  M. Robinson,et al.  Clathrin, adaptors, and sorting. , 1990, Annual review of cell biology.

[22]  J. Angel,et al.  IL‐7‐dependent STAT‐5 activation and CD8+ T cell proliferation are impaired in HIV infection , 2011, Journal of leukocyte biology.

[23]  G. Silvestri,et al.  Immune activation and AIDS pathogenesis. , 2008, AIDS.

[24]  T. Fry,et al.  Interleukin-7 restores immunity in athymic T-cell-depleted hosts. , 2001, Blood.

[25]  Hans Hengartner,et al.  Inverse correlation between IL‐7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation , 2005, European journal of immunology.

[26]  T. Taniguchi,et al.  Organization of the murine and human interleukin-7 receptor genes: two mRNAs generated by differential splicing and presence of a type I-interferon-inducible promoter , 1991, Molecular and cellular biology.

[27]  C. Mackall,et al.  Modulating T‐cell homeostasis with IL‐7: preclinical and clinical studies , 2009, Journal of internal medicine.

[28]  J. Kakal,et al.  IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells. , 2009, International immunology.

[29]  B. Assouline,et al.  A validated assay to measure soluble IL-7 receptor shows minimal impact of IL-7 treatment. , 2010, Journal of immunological methods.

[30]  E. Kim,et al.  Immunotherapeutic effects of IL-7 during a chronic viral infection in mice. , 2011, Blood.

[31]  J. Sprent,et al.  Interleukin (IL)-15 and IL-7 Jointly Regulate Homeostatic Proliferation of Memory Phenotype CD8+ Cells but Are Not Required for Memory Phenotype CD4+ Cells , 2002, The Journal of experimental medicine.

[32]  M. Magnani,et al.  Increased Bone Marrow Interleukin-7 (IL-7)/IL-7R Levels but Reduced IL-7 Responsiveness in HIV-Positive Patients Lacking CD4+ Gain on Antiviral Therapy , 2010, PloS one.

[33]  Richard Murray,et al.  IL-7 is critical for homeostatic proliferation and survival of naïve T cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  E. Chiappini,et al.  Interleukin-7 and immunologic failure despite treatment with highly active antiretroviral therapy in children perinatally infected with HIV-1. , 2003, Journal of acquired immune deficiency syndromes.

[35]  Marcus Schmidt,et al.  Reduced numbers of IL‐7 receptor (CD127) expressing immune cells and IL‐7‐signaling defects in peripheral blood from patients with breast cancer , 2007, International journal of cancer.

[36]  T. Fry,et al.  Interleukin-7: from bench to clinic. , 2002, Blood.

[37]  C. Mackall,et al.  Perspective on Potential Clinical Applications of Recombinant Human Interleukin‐7 , 2009, Annals of the New York Academy of Sciences.

[38]  M. McVey,et al.  Soluble HIV Tat Protein Removes the IL-7 Receptor α-Chain from the Surface of Resting CD8 T Cells and Targets It for Degradation , 2010, The Journal of Immunology.

[39]  T. Fry,et al.  IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. , 2001, Blood.

[40]  M. Moroni,et al.  Il-7/Il-7 Receptor System Regulation following Il-2 Immunotherapy in HIV-Infected Patients , 2003, Antiviral therapy.

[41]  T. Fry,et al.  The Many Faces of IL-7: From Lymphopoiesis to Peripheral T Cell Maintenance , 2005, The Journal of Immunology.

[42]  D. Booth,et al.  Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis , 2008, Genes and Immunity.

[43]  F. Barré-Sinoussi,et al.  Interleukin-7 and infection itself by human immunodeficiency virus 1 favor virus persistence in mature CD4(+)CD8(-)CD3(+) thymocytes through sustained induction of Bcl-2. , 2001, Blood.

[44]  S. Levine.  Molecular Mechanisms of Soluble Cytokine Receptor Generation* , 2008, Journal of Biological Chemistry.

[45]  Yili Yang,et al.  Dynamic regulation of IL-7 receptor expression is required for normal thymopoiesis. , 2004, Blood.

[46]  R. Mazzucchelli,et al.  Live from the liver: hepatocyte IL-7. , 2009, Immunity.

[47]  C. Eckert,et al.  Expression analysis and characterization of alternatively spliced transcripts of human IL-7Ralpha chain encoding two truncated receptor proteins in relapsed childhood all. , 2000, Cytokine.

[48]  B. Wahrén,et al.  Increased levels of interferon‐gamma (IFN‐γ), IL‐4 and transforming growth factor‐beta (TGF‐β) mRNA expressing blood mononuclear cells in human HIV infection , 1994 .

[49]  P. Ye,et al.  The thymus during HIV disease: role in pathogenesis and in immune recovery. , 2004, Current HIV research.

[50]  Nikhil S. Joshi,et al.  Formation of IL-7Ralphahigh and IL-7Ralphalow CD8 T cells during infection is regulated by the opposing functions of GABPalpha and Gfi-1. , 2008, Journal of immunology.

[51]  H. Keller,et al.  Defective interleukin-2-dependent STAT5 signalling in CD8 T lymphocytes from HIV-positive patients: restoration by antiretroviral therapy , 2004, AIDS.

[52]  G. Friedman,et al.  Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice. , 1996, Experimental hematology.

[53]  Angelo Vanzulli,et al.  Thymic volume predicts long-term immune reconstitution in HIV-infected children treated with highly active antiretroviral therapy. , 2002, AIDS.

[54]  N. Ampel,et al.  Peripheral blood from human immunodeficiency virus type 1-infected patients displays diminished T cell generation capacity. , 1997, The Journal of infectious diseases.

[55]  M. Clerici,et al.  A TH1-->TH2 switch is a critical step in the etiology of HIV infection. , 1993, Immunology today.

[56]  O. Lambotte,et al.  Dual Mechanism of Impairment of Interleukin-7 (IL-7) Responses in Human Immunodeficiency Virus Infection: Decreased IL-7 Binding and Abnormal Activation of the JAK/STAT5 Pathway , 2009, Journal of Virology.

[57]  R. Lier,et al.  Signaling Expression by IL-7 and TCR α Receptor Differential Regulation of Human IL-7 Derks and , 2008 .

[58]  D. Franchimont,et al.  Positive Effects of Glucocorticoids on T Cell Function by Up-Regulation of IL-7 Receptor α1 , 2002, The Journal of Immunology.

[59]  D. Cooper,et al.  IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers. , 2010, Cytokine.

[60]  D. Clark,et al.  Selective thymocyte depletion in neonatal HIV-1 thymic infection , 1993, AIDS.

[61]  A. Sinicco,et al.  Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis. , 1996, Clinical immunology and immunopathology.

[62]  J. Zack,et al.  CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus , 1997, Journal of virology.

[63]  J. Angel,et al.  Interleukin-7 receptor expression on CD8(+) T cells is reduced in HIV infection and partially restored with effective antiretroviral therapy. , 2001, Journal of acquired immune deficiency syndromes.

[64]  F. Chiodi,et al.  Loss of IL-7Rα is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients , 2005, AIDS.

[65]  T. Gingeras,et al.  HIV regulation of the IL‐7R: a viral mechanism for enhancing HIV‐1 replication in human macrophages in vitro , 2006, Journal of leukocyte biology.

[66]  M. Lederman,et al.  IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. , 2009, Blood.

[67]  D. Booth,et al.  Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis , 2005, Journal of Molecular Medicine.

[68]  R. Fernandez-Botran,et al.  Soluble cytokine receptors in biological therapy , 2002, Expert opinion on biological therapy.

[69]  R. Badolato,et al.  IL-7 activates alpha4beta1 integrin in murine thymocytes. , 1997, Journal of immunology.

[70]  Robert E. Miller,et al.  In vivo evaluation of the effects of interleukins 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti‐tumor cytotoxic T lymphocytes , 1991, European journal of immunology.

[71]  Daniel C. Douek,et al.  CD127 and CD25 Expression Defines CD4+ T Cell Subsets That Are Differentially Depleted during HIV Infection 1 , 2008, The Journal of Immunology.

[72]  A. Kelleher,et al.  The IL-7/IL-7 receptor axis: understanding its central role in T-cell homeostasis and the challenges facing its utilization as a novel therapy. , 2006, Current drug targets.

[73]  S. Rowland-Jones,et al.  Skewed maturation of memory HIV-specific CD8 T lymphocytes , 2001, Nature.

[74]  J. Angel,et al.  Optimization of culture and storage conditions for an in vitro system to evaluate thymocyte phenotype and function. , 2006, Journal of immunological methods.

[75]  Alternative splicing of interleukin-7 (IL-7) and interleukin-7 receptor alpha (IL-7Rα) in peripheral blood from patients with multiple sclerosis (MS) , 2010, Journal of Neuroimmunology.

[76]  K. Weinberg,et al.  Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. , 1996, Blood.

[77]  Hermann Wagner,et al.  Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[78]  J. Angel,et al.  Interleukin‐4 downregulates CD127 expression and activity on human thymocytes and mature CD8+ T cells , 2010, European journal of immunology.

[79]  J. Angel,et al.  Soluble IL-7Rα (sCD127) Inhibits IL-7 Activity and Is Increased in HIV Infection , 2010, The Journal of Immunology.

[80]  S. Rosenberg,et al.  IL-7 Administration to Humans Leads to Expansion of CD8+ and CD4+ Cells but a Relative Decrease of CD4+ T-Regulatory Cells , 2006, Journal of immunotherapy.

[81]  J. Bonifacino,et al.  Protein targeting by tyrosine- and di-leucine-based signals: evidence for distinct saturable components , 1996, The Journal of cell biology.

[82]  G. Stewart,et al.  Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation. , 2010, The Journal of infectious diseases.

[83]  Silke Schmidt,et al.  Interleukin 7 receptor α chain ( IL7R ) shows allelic and functional association with multiple sclerosis , 2007, Nature Genetics.

[84]  J. Bartlett,et al.  IL‐7 enhancement of antigen‐driven activation/expansion of HIV‐1‐specific cytotoxic T lymphocyte precursors (CTLp) , 1995, Clinical and experimental immunology.

[85]  Denis Puthier,et al.  Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV , 2005, AIDS.

[86]  M. McVey,et al.  Interleukin-7 Receptor Expression on CD8 T-Cells Is Downregulated by the HIV Tat Protein , 2006, Journal of acquired immune deficiency syndromes.

[87]  O. Katoh,et al.  Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevance. , 1995, Cytokine.

[88]  R. Mazzucchelli,et al.  Interleukin-7 receptor expression: intelligent design , 2007, Nature Reviews Immunology.

[89]  B. Wahrén,et al.  Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection. , 1994, Clinical and experimental immunology.

[90]  T. Hirano,et al.  Hepatic interleukin-7 expression regulates T cell responses. , 2009, Immunity.

[91]  H. Harbo,et al.  Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. , 2007, Nature genetics.

[92]  A. Dautry‐Varsat,et al.  Endocytosis of the common cytokine receptor gammac chain. Identification of sequences involved in internalization and degradation. , 1998, The Journal of biological chemistry.

[93]  D. Douek,et al.  IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. , 2003, Blood.

[94]  K. Muegge,et al.  Interleukin-7: physiological roles and mechanisms of action. , 1999, Cytokine & growth factor reviews.

[95]  S. Rosenberg,et al.  Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy. , 2005, Blood.

[96]  Kaushal S. Gandhi,et al.  Functionally Significant Differences in Expression of Disease-Associated IL-7 Receptor α Haplotypes in CD4 T Cells and Dendritic Cells , 2010, The Journal of Immunology.

[97]  T. Gingeras,et al.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.

[98]  L. Ryder,et al.  Reduced Thymic Size but No Evidence of Impaired Thymic Function in Uninfected Children Born to Human Immunodeficiency Virus-infected Mothers , 2011, The Pediatric infectious disease journal.

[99]  C. Carini,et al.  Dysregulation of interleukin‐7 receptor may generate loss of cytotoxic T cell response in human immunodeficiency virus type 1 infection , 1994, European journal of immunology.

[100]  A. Goldrath,et al.  Surviving the crash: transitioning from effector to memory CD8+ T cell. , 2009, Seminars in immunology.

[101]  M. Lederman,et al.  A potential role for interleukin-7 in T-cell homeostasis. , 2001, Blood.

[102]  J. McCune,et al.  Human immunodeficiency virus-1 infection interrupts thymopoiesis and multilineage hematopoiesis in vivo. , 1998, Blood.

[103]  B. Walker,et al.  HIV-specific CD8 T cells express low levels of IL-7Ralpha: implications for HIV-specific T cell memory. , 2006, Virology.

[104]  N. Minato,et al.  IL-7 promotes thymocyte proliferation and maintains immunocompetent thymocytes bearing alpha beta or gamma delta T-cell receptors in vitro: synergism with IL-2. , 1989, Journal of immunology.

[105]  G. Bahr,et al.  Variations in serum IL‐7 and 90K/Mac‐2 binding protein (Mac−2 BP) levels analysed in cohorts of HIV‐1 patients and correlated with clinical changes following antiretroviral therapy , 2001, Clinical and experimental immunology.

[106]  Ashok Kumar,et al.  IL-7 decreases IL-7 receptor alpha (CD127) expression and induces the shedding of CD127 by human CD8+ T cells. , 2007, International immunology.

[107]  J. Angel,et al.  In vitro HIV Type 1 infection indirectly alters CD127 expression on CD8(+) T cells. , 2012, AIDS research and human retroviruses.

[108]  J. Alimonti,et al.  IL‐7Rα expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation , 2006, European journal of immunology.

[109]  R. Damico,et al.  Human neonatal thymic organ culture: an ex vivo model of thymocyte ontogeny and HIV-1 infection. , 1994, Pathobiology : journal of immunopathology, molecular and cellular biology.

[110]  W. Leonard,et al.  IL-2 negatively regulates IL-7 receptor α chain expression in activated T lymphocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[111]  S. Modrow,et al.  Pathogenesis , 2013, Molecular Virology.

[112]  L. Picker,et al.  Increased CD4+ T Cell Levels during IL-7 Administration of Antiretroviral Therapy-Treated Simian Immunodeficiency Virus-Positive Macaques Are Not Dependent on Strong Proliferative Responses , 2010, Journal of Immunology.

[113]  F. Barré-Sinoussi,et al.  Differential susceptibility of human thymic dendritic cell subsets to X4 and R5 HIV-1 infection , 2006, AIDS.

[114]  S. Jameson,et al.  Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo , 2000, Nature Immunology.

[115]  I. Kang,et al.  Down-Regulation of IL-7Rα Expression in Human T Cells via DNA Methylation1 , 2007, The Journal of Immunology.

[116]  J. Altman,et al.  Loss of CD127 Expression Defines an Expansion of Effector CD8+ T Cells in HIV-Infected Individuals1 , 2005, The Journal of Immunology.

[117]  D. Cooper,et al.  Increased plasma interleukin-7 level correlates with decreased CD127 and Increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection. , 2006, The Journal of infectious diseases.

[118]  O. Lambotte,et al.  Identification and Biochemical Characterization of Human Plasma Soluble IL-7R: Lower Concentrations in HIV-1-Infected Patients1 , 2009, The Journal of Immunology.

[119]  J. McCune,et al.  Effects of IL-7 on Early Human Thymocyte Progenitor Cells In Vitro and in SCID-hu Thy/Liv Mice1 , 2003, The Journal of Immunology.

[120]  R. Grant,et al.  Increased production of IL-7 accompanies HIV-1–mediated T-cell depletion: implications for T-cell homeostasis , 2001, Nature Medicine.

[121]  B. Haynes,et al.  Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[122]  D. Golde,et al.  Soluble receptors in human disease , 1998, Journal of leukocyte biology.

[123]  R. Cheynier,et al.  IL-7 Induces Immunological Improvement in SIV-Infected Rhesus Macaques under Antiviral Therapy1 , 2006, The Journal of Immunology.

[124]  O. Lambotte,et al.  CD127 expression and regulation are altered in the memory CD8 T cells of HIV‐infected patients − reversal by highly active anti‐retroviral therapy (HAART) , 2006, Clinical and experimental immunology.

[125]  W. Selby,et al.  Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells , 2006, The Journal of experimental medicine.

[126]  E. Rosenberg,et al.  Infection of CD127+ (Interleukin-7 Receptor+) CD4+ Cells and Overexpression of CTLA-4 Are Linked to Loss of Antigen-Specific CD4 T Cells during Primary Human Immunodeficiency Virus Type 1 Infection , 2006, Journal of Virology.

[127]  W. Leonard,et al.  IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[128]  R. Fernandez-Botran.  Soluble cytokine receptors: basic immunology and clinical applications. , 1999, Critical reviews in clinical laboratory sciences.

[129]  Jingwu Z. Zhang,et al.  Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease , 2010, Nature Medicine.

[130]  B. Agan,et al.  Responsiveness of T cells to interleukin-7 is associated with higher CD4+ T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced viral load suppression. , 2009, The Journal of infectious diseases.

[131]  Jeffrey L. Wrana,et al.  Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling , 2005, Nature Reviews Molecular Cell Biology.

[132]  Y. Kita,et al.  Role of glycosaminoglycans in the regulation of T cell proliferation induced by thymic stroma-derived T cell growth factor. , 1991, Journal of Immunology.

[133]  J. Klarquist,et al.  Loss of IL‐7 receptor alpha‐chain (CD127) expression in acute HCV infection associated with viral persistence , 2006, Hepatology.